Press Releases

05.12.2020

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

05.08.2020

Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting

05.05.2020

Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program

05.04.2020

New Data Suggest Burden of Group B Streptococcus (GBS) Infection in U.S. Adults Greater Than Previously Recognized

04.30.2020

Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15

04.30.2020

AMRA Medical renews collaboration with Pfizer Inc. aiming to generate the world’s largest imaging dataset on body composition profiling

04.29.2020

BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany

04.28.2020

PFIZER REPORTS FIRST-QUARTER 2020 RESULTS

04.23.2020

Pfizer Hosts Virtual-Only Annual Meeting of Shareholders

04.22.2020

FoRx Therapeutics AG Raises EUR 10 Million Seed Round to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer

04.22.2020

BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates

04.20.2020

Valneva Receives FDA Fast Track Designation for its Lyme Disease Vaccine Candidate VLA15